600479.SS · 千金药业
China A-shares · RS rating 84 · As of 2026-10-14
| Price | 11.59 CNY |
|---|---|
| 1-day change | -1.9% |
| RS rating (overall / 1M / 3M / 12M) | 84 / 13 / 91 / 80 |
| Stage | Topping |
| Composite / Minervini / CANSLIM score | 38 / 47 / 37 |
| Industry group (rank) | Medical-Generic Drugs (40) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | +6.6% |
| Distance from 52-week high | +21.7% |
| Market cap (USD) | $892.9M |